Clinical Trials in Age-Related Macular Degeneration Treatment

• Autore: Weiss Jeffrey N
• Pubblicazione: Cham : , : Springer International Publishing AG, , 2024; ©2024
• Edizione: 1st ed.
• Descrizione fisica: 1 online resource (300 pages)
• Nota di contenuto: Intro -- Preface -- Contents -- Chapter 1: Introduction to Age-Related Macular Degeneration -- Further Reading -- Chapter 2: Tables -- Chapter 3: Stem Cell Studies -- United States -- Recruiting -- Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Transplantation in Patients with Dry Age-Related Macular Degeneration (AMD) -- ClinicalTrials.gov ID NCT04627428 -- United States -- Recruiting -- Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT04339764 -- United States -- Recruiting -- Stem Cell Ophthalmology Treatment Study II (SCOTS2) -- ClinicalTrials.gov ID NCT03011541 -- United States -- Recruiting -- A Study of the Safety and Tolerability of ASP7317 in Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT03178149 -- Caribbean -- Recruiting -- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases -- ClinicalTrials.gov ID NCT05147701 -- China -- Not Yet Recruiting -- Preparation of Patient Autologous-Induced Pluripotent Stem Cell-Derived Retinal Cells for AMD -- ClinicalTrials.gov ID NCT05991986 -- China -- Recruiting -- Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration -- ClinicalTrials.gov ID NCT05445063 -- Great Britain -- Recruiting -- A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT01691261 -- Great Britain -- Not Yet Recruiting -- Retinal Pigment Epithelium Safety Study for Patients in B4711001 -- ClinicalTrials.gov ID NCT03102138 -- Chapter 4: Gene Therapy Trials -- United States. ; Not Yet Recruiting -- Phase I/II Study of SKG0106 Intraocular Solution in Patients with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05986864 -- United States -- Recruiting -- 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05197270 -- United States -- Recruiting -- RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants with Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE) -- ClinicalTrials.gov ID NCT04514653 -- United States -- Recruiting -- Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients with Neovascular Age-Related Macular Degeneration [LUNA] -- ClinicalTrials.gov ID NCT05536973 -- United States -- Recruiting -- A Study of EXG102-031 in Patients with wAMD (Everest) -- ClinicalTrials.gov ID NCT05903794 -- United States -- Recruiting -- Pivotal 2 Study of RGX-314 Gene Therapy in Participants with nAMD (ASCENT) -- ClinicalTrials.gov ID NCT05407636 -- United States -- Recruiting -- Pivotal 1 Study of RGX-314 Gene Therapy in Participants with nAMD (ATMOSPHERE) -- ClinicalTrials.gov ID NCT04704921 -- Canada -- Recruiting -- NG101 AAV Gene Therapy in Subjects with Wet Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05984927 -- China -- Recruiting -- Safety and Tolerability of KH631 Gene Therapy in Participants with Neovascular Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05657301 -- China -- Recruiting -- Safety and Tolerability of KH631 Gene Therapy in Subjects with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05672121 -- China -- Not Yet Recruiting -- Gene Therapy for Wet AMD -- ClinicalTrials.gov ID NCT05611424 -- China -- Recruiting -- CRISPR/Cas13-Mediated RNA Targeting Therapy for the Treatment of nAMD Investigator-Initiated Trial (SIGHT-I). ; ClinicalTrials.gov ID NCT06031727 -- China -- Recruiting -- VEGFA-Targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases -- ClinicalTrials.gov ID NCT05099094 -- China -- Not Yet Recruiting -- An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients with nAMD -- ClinicalTrials.gov ID NCT06022744 -- Chapter 5: Other Trials -- United States -- Recruiting -- Microcurrent Stimulation Therapy for Nonexudative Age-Related Macular Degeneration (i-SIGHT) -- ClinicalTrials.gov ID NCT05447650 -- United States -- Recruiting -- A Masked, Placebo-Controlled Study to Assess Iptacopan in Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05230537 -- United States -- Recruiting -- Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants with Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD) -- ClinicalTrials.gov ID NCT05893537 -- United States -- Recruiting -- Evaluation of OLX10212 in Patients with Neovascular Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05643118 -- United States -- Recruiting -- Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration (ODYSSEY) -- ClinicalTrials.gov ID NCT05891548 -- United States -- Recruiting -- Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients with Neovascular Age-Related Macular Degeneration [LUNA] -- ClinicalTrials.gov ID NCT05536973 -- United States -- Recruiting -- Study of Zifibancimig in Participants with Neovascular Age-Related Macular Degeneration (BURGUNDY) -- ClinicalTrials.gov ID NCT04567303 -- United States -- Not Yet Recruiting -- Non-invasive Ultrasound Retinal Stimulation for Vision Restoration -- ClinicalTrials.gov ID NCT05914233 -- United States -- Recruiting. ; A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants with Geographic Atrophy Secondary to Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05626114 -- United States -- Recruiting -- Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy (PHOENIX) -- ClinicalTrials.gov ID NCT05949593 -- Australia -- Not Yet Recruiting -- Safety of BBC1501 Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05803785 -- Australia -- Recruiting -- Subthreshold Laser Treatment in Intermediate Age-Related Macular Degeneration with Nascent Geographic Atrophy Study (LIANA) -- ClinicalTrials.gov ID NCT05200624 -- Austria -- Recruiting -- Faricimab for High-Frequent Aflibercept Treated Neovascular Age-Related Macular Degeneration (FAN) -- ClinicalTrials.gov ID NCT05941715 -- Austria -- Recruiting -- Therapy of Age-Related Macular Degeneration (MET) -- ClinicalTrials.gov ID NCT05222997 -- China -- Not Yet Recruiting -- A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-Related Macular Degeneration (wAMD) -- ClinicalTrials.gov ID NCT04572698 -- China -- Recruiting -- Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with wAMD -- ClinicalTrials.gov ID NCT05003245 -- China -- Recruiting -- A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with wAMD -- ClinicalTrials.gov ID NCT04740671 -- China -- Recruiting -- Treatment of Recalcitrant Neovascular AMD Using Brolocizumab with Immediate T& -- E -- ClinicalTrials.gov ID NCT05710471 -- China -- Recruiting -- Study of IBI333 in Subjects with Neovascular Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05639530 -- China -- Recruiting. ; QA108 Phase II Study in Subjects with Intermediate Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05562219 -- Italy -- Recruiting -- Photobiomodulation in Dry Age-Related Macular Degeneration (DRUSEN) -- ClinicalTrials.gov ID NCT06046118 -- Korea -- Recruiting -- Study of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05259371 -- Norway -- Not Yet Recruiting -- Photobiomodulation for Dry Age-Related Macular Degeneration -- ClinicalTrials.gov ID NCT05507840 -- South America -- Recruiting -- OcuDyne System in the Treatment of AMD -- ClinicalTrials.gov ID NCT05091476 -- Thailand -- Recruiting -- A Study to Investigate the Effect on Central Macular Thickness of Treatment with MG-O-1002 Eye Drops in Participants Aged over 45 with Neovascular Age-Related Macular Degeneration (nAMD) -- ClinicalTrials.gov ID NCT05390840 -- Index.
• Titolo autorizzato: Clinical Trials in Age-Related Macular Degeneration Treatment
• ISBN: 9783031588037; 9783031588020
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910872187903321
• Lo trovi qui: Univ. Federico II